Your session is about to expire
← Back to Search
PACHA Program for Breast Cancer (PACHA Trial)
PACHA Trial Summary
This trial will assess how a community pharmacy-based program impacts adherence and experience of women having AET after hormone-sensitive breast cancer.
PACHA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPACHA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PACHA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the maximum number of participants accepted for this medical research?
"Affirmative. According to clinicaltrials.gov, the mentioned trial was first advertised on June 7th 2023 and has been recently revised on September 8th 2023. 66 patients have to be enrolled from one medical facility for this investigation."
Is enrollment for this experiment available to participants at the moment?
"The clinical trial is currently in the process of recruiting patients, according to information posted on clinicaltrials.gov. This study was initially listed on June 7th 2023 and has been updated as recently as September 8th 2023."
What is the primary purpose of this clinical research?
"The primary objective of the trial, which is evaluated over a baseline and 6-month postrandomisation period, is to measure the percentage of qualified women enrolled in the study. Secondary goals include gauging program acceptability and feasibility through interviews conducted with pharmacists and participants (in intervention group only), assessing how many women receive adjuvant endocrine therapy via questionnaire data and pharmacy records analysis, as well as calculating the proportion of days covered by this treatment based on similar methods."
Share this study with friends
Copy Link
Messenger